| Literature DB >> 14622094 |
Hiroaki Terada1, Masayuki Matsushita, Yun-Fei Lu, Takeshi Shirai, Sheng-Tian Li, Kazuhito Tomizawa, Akiyoshi Moriwaki, Shinsaku Nishio, Isao Date, Takashi Ohmoto, Hideki Matsui.
Abstract
In glutamate-mediated excitatory neuronal cell death, immunosuppressants (FK506, Cys-A) are powerful agents that protect neurons from apoptosis. Immunosuppressants inhibit two types of enzyme, calcium/calmodulin-dependent protein phosphatase (calcineurin: CaN), and peptidyl-prolyl cis-trans-isomerase (PPIase) activity such as the FKBP family. In this study, we used a protein transduction approach to determine the functional role of CaN and to produce a potential therapeutic agent for glutamate-mediated neuronal cell death. We created a novel cell-permeable CaN autoinhibitory peptide using the 11 arginine protein transduction domain. This peptide was highly efficient at transducing into primary culture neurons, potently inhibited CaN phosphatase activities, and inhibited glutamate-mediated neuronal cell death. These results showed that CaN plays an important role in excitatory neuronal cell death and cell-permeable CaN autoinhibitory peptide could be a new drug to protect neurons from excitatory neuronal death.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14622094 DOI: 10.1046/j.1471-4159.2003.02098.x
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372